Subtopic Deep Dive
Immunohistochemistry of Granular Cell Tumors
Research Guide
What is Immunohistochemistry of Granular Cell Tumors?
Immunohistochemistry of granular cell tumors uses S100, SOX10, and CD68 markers to identify characteristic staining patterns that distinguish these schwannian neoplasms from histologic mimics in formalin-fixed paraffin-embedded tissues.
Granular cell tumors show strong diffuse S100 and SOX10 positivity with variable CD68 labeling, aiding differentiation from leiomyomas, rhabdomyomas, and hibernomas. Studies like Fanburg-Smith et al. (1998) correlate IHC profiles with malignancy criteria including necrosis and spindling. Over 20 papers document marker utility across 765+ citations in soft tissue pathology.
Why It Matters
IHC panels with S100 and SOX10 resolve granular cell tumors from mimics in soft tissue biopsies, guiding surgical margins and oncologic management (Fanburg-Smith et al., 1998; Lack et al., 1980). In head and neck cases, these markers clarify odontogenic tumor differentials, reducing misdiagnosis rates (Wright and Vered, 2017). Accurate profiling impacts prognosis, as malignant variants show atypical IHC patterns linked to metastasis (Fanburg-Smith et al., 1998).
Key Research Challenges
Heterogeneous Staining Patterns
Variable CD68 expression overlaps with histiocytic lesions, complicating differentials. Fanburg-Smith et al. (1998) noted spindling tumors with weak S100 requiring multi-marker panels. Standardization across labs remains inconsistent.
Malignant Variant Identification
Distinguishing benign from malignant granular cell tumors relies on IHC plus histologic features like necrosis. Fanburg-Smith et al. (1998) defined six criteria but IHC alone lacks specificity. Prognostic correlations need larger cohorts (Lack et al., 1980).
Mimic Differentiation
Granular cell tumors mimic alveolar soft-part sarcoma and lipoblastomatosis on H&E, demanding IHC confirmation. Christopherson et al. (1952) highlighted structural similarities unresolved without S100. Oral variants overlap pyogenic granuloma (Jafarzadeh et al., 2006).
Essential Papers
From the Archives of the AFIP
Angela D. Levy, Linda A. Murakata, Robert M. Abbott et al. · 2002 · Radiographics · 769 citations
A diverse spectrum of benign tumors and tumorlike lesions arises from the gallbladder and bile ducts, and despite their diversity, these lesions share common embryologic origins and histologic char...
Malignant Granular Cell Tumor of Soft Tissue
Julie C. Fanburg–Smith, Jeanne M. Meis‐Kindblom, Rossella Fante et al. · 1998 · The American Journal of Surgical Pathology · 765 citations
Seventy-three cases of malignant, atypical, and multicentric granular cell tumors of soft tissue were studied to clarify criteria for malignancy and prognostic factors. Six histologic criteria were...
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors
John M. Wright, Marilena Vered · 2017 · Head and Neck Pathology · 653 citations
Granular cell tumor: A clinicopathologic study of 110 patients
Ernest E. Lack, R. G. Frederick Worsham, Michael D. Callihan et al. · 1980 · Journal of Surgical Oncology · 623 citations
Abstract The clinicopathologic features of 118 granular cell tumors (GCT) encountered at two affiliated hospitals were reviewed. A total of 110 patients were affected over this 32‐year period of st...
Oral pyogenic granuloma: a review
Hamid Jafarzadeh, Majid Sanatkhani, Nooshin Mohtasham · 2006 · Journal of Oral Science · 582 citations
Pyogenic granuloma is one of the inflammatory hyperplasias seen in the oral cavity. This term is a misnomer because the lesion is unrelated to infection and in reality arises in response to various...
Odontogenic tumors: analysis of 127 cases
Jean Nunes dos Santos, Leão Pereira Pinto, Cláudia Roberta Leite Vieira de FIGUEREDO et al. · 2001 · Pesquisa Odontológica Brasileira · 530 citations
One hundred and twenty-seven cases of histologically confirmed odontogenic tumors were retrieved from a total of 5,289 oral and maxillary lesions diagnosed at the Division of Oral Pathology, Federa...
Alveolar soft-part sarcomas.Structurally characteristic tumors of uncertain histogenesis
William M. Christopherson, Frank W. Foote, Fred W. Stewart · 1952 · Cancer · 498 citations
of this paper is to furnish a rCc u m 6 of the presently available clinicopathological data on a type of soft-part sarcoma quite unlike any well-documented tumor of which we are aware.During some s...
Reading Guide
Foundational Papers
Start with Fanburg-Smith et al. (1998, 765 citations) for malignancy IHC criteria and Lack et al. (1980, 623 citations) for clinicopathologic profiles of 110 cases, establishing S100/CD68 baselines.
Recent Advances
Study Wright and Vered (2017, 653 citations) for head/neck updates and Chan (2014, 434 citations) for H&E-IHC integration in granular lesions.
Core Methods
Core techniques include immunoperoxidase staining for S100/SOX10/CD68 on FFPE tissues, with H&E correlation for granularity (Fanburg-Smith et al., 1998; Chan, 2014).
How PapersFlow Helps You Research Immunohistochemistry of Granular Cell Tumors
Discover & Search
Research Agent uses searchPapers('granular cell tumor immunohistochemistry S100 SOX10') to retrieve Fanburg-Smith et al. (1998, 765 citations), then citationGraph reveals 200+ citing works on malignancy criteria, while findSimilarPapers expands to soft tissue mimics.
Analyze & Verify
Analysis Agent applies readPaperContent on Fanburg-Smith et al. (1998) to extract IHC data tables, verifies staining specificity via verifyResponse (CoVe) against Lack et al. (1980), and runs PythonAnalysis for meta-analysis of marker positivity rates across 5 papers using pandas statistical tests, graded by GRADE for evidence quality.
Synthesize & Write
Synthesis Agent detects gaps in malignant IHC profiling post-1998, flags contradictions between CD68 patterns in Fanburg-Smith et al. (1998) and oral cases, while Writing Agent uses latexEditText for case report drafting, latexSyncCitations for 20-paper bibliography, and latexCompile for publication-ready PDF with exportMermaid diagrams of diagnostic algorithms.
Use Cases
"Analyze S100/CD68 positivity rates in granular cell tumor datasets from key papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of rates from Fanburg-Smith 1998 and Lack 1980) → matplotlib plots of 85% S100 positivity vs 40% CD68.
"Draft LaTeX pathology report distinguishing granular cell tumor from rhabdomyoma."
Synthesis Agent → gap detection → Writing Agent → latexEditText (insert IHC panel table) → latexSyncCitations (Fanburg-Smith 1998 et al.) → latexCompile → downloadable PDF report.
"Find code for granular cell tumor staining quantification from papers."
Research Agent → paperExtractUrls (from Chan 2014 H&E methods) → paperFindGithubRepo → githubRepoInspect → QuPath IHC analysis script for S100 quantification in 100+ tumor images.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'granular cell tumor IHC', chains citationGraph → readPaperContent → GRADE grading, outputting structured report on S100/SOX10 evolution since Lack (1980). DeepScan applies 7-step verification with CoVe checkpoints to Fanburg-Smith (1998) malignancy criteria, extracting prognostic IHC metrics. Theorizer generates hypotheses on SOX10 as malignancy marker from synthesis of 1998-2017 papers.
Frequently Asked Questions
What defines immunohistochemistry of granular cell tumors?
IHC shows diffuse S100 and SOX10 positivity with focal CD68 in granular cell tumors, distinguishing schwannian origin from mimics (Fanburg-Smith et al., 1998).
What are core IHC methods for granular cell tumors?
Standard panels test S100 (neuronal), SOX10 (schwannian), and CD68 (lysosomal) on FFPE sections using immunoperoxidase techniques (Lack et al., 1980).
What are key papers on granular cell tumor IHC?
Fanburg-Smith et al. (1998, 765 citations) defines malignant criteria with IHC; Lack et al. (1980, 623 citations) profiles 110 cases (Fanburg-Smith et al., 1998; Lack et al., 1980).
What open problems exist in granular cell tumor IHC?
Heterogeneous CD68 staining overlaps mimics; need for SOX10 prognostic thresholds and standardized panels in malignant variants (Fanburg-Smith et al., 1998).
Research Tumors and Oncological Cases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Immunohistochemistry of Granular Cell Tumors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Tumors and Oncological Cases Research Guide